Yourgene Health

Yourgene Health offers a comprehensive suite of non-invasive prenatal testing (NIPT) solutions, including a complete NGS workflow designed to provide laboratories with flexible, scalable testing and a broad clinical menu, tailored to their needs. In addition, Yourgene provide a clinical NIPT sample service through the Manchester Genomic Service Laboratory for healthcare professionals. Supporting the wider reproductive lifecycle, Yourgene offer a portfolio of PCR-based clinical screening assays, including tests for cystic fibrosis, aneuploidy analysis, pregnancy loss, male factor infertility, and thrombosis risk. As part of the expanding Precision Medicine portfolio, the Yourgene® DPYD genotyping PCR assay supports safer chemotherapy regimes, by identifying patients at risk of severe fluoropyrimidine toxicity. Early detection of DPD deficiency before starting 5-FU treatment enables clinicians to adjust chemotherapy dosing and avoid serious, potentially life-threatening adverse reactions. Powered by Ranger® Technology, Yourgene’s portfolio of automated DNA size selection instruments delivers high-precision fragment selection and dynamic target enrichment across a wide range of clinical and research sequencing applications. Designed to support laboratories from low- to high-throughput workflows, Ranger® instruments provide an innovative solution for applications including NIPT, gene synthesis, CRISPR gene editing, and long-read sequencing. The LightBench® Discover is an automated 3-in-1 electrophoresis system combining DNA size selection, fragment length analytics, and quantification in a single benchtop solution, removing the need for multiple instruments and simplifying laboratory workflows. Yourgene Health is headquartered in Manchester, UK with facilities in Singapore, the US and Canada. Yourgene is part of the Novacyt group of companies. Visit yourgenehealth.com for further information, or contact info@yourgenehealth.com